Today, BioIQ announced that it has conducted its one millionth colorectal cancer (CRC) screening. The company reached this notable milestone by leveraging convenient CRC kits and facilitating care using consumer analytics, omni-channel engagement and a curated network of partner solutions. BioIQ helps some of the nation’s largest health plans screen at-risk members for CRC with a powerful technology platform and a-simple-to-use, at-home test kit.
Promotion of CRC screening, especially among at-risk populations, is a national priority. American adults aged 50 to 75 years who were up to date with colorectal cancer screening increased 1.1 percentage points, from 66.2% in 2014 to 67.3% in 2016.2 And with the American Cancer Society lowering the recommended age that screening should start —from 50 to 45— even more unscreened people need this critical test.
“Our mission is to positively change the nation’s healthcare system by making it easier and more convenient for people to understand their health and take action,” said Justin Bellante, CEO of BioIQ. “Providing a personalized, convenient CRC screening to people in the comfort of their home saves lives and is an important example of what we can do to improve healthcare.”
Check out the slideshow below to learn important facts and stats about screening for this preventable disease.